col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


120 Results       Page 1

 [1] 
SAGE Publications: Clinical and Applied Thrombosis/Hemostasis
  original article Date Title Authors   All Authors
1 [GO] 2026―May―08 Prognostic Value of Serum Salusin-α and Salusin-β in COVID-19 Patients Safiye Bilge Guclu Kayta, Sevil Alkan Varoglu, Havva Yasemin Cinpolat, Taylan Onder, Isil Deniz Aliravci
2 [GO] 2025―Sep―18 Coagulation Biomarkers and Mortality in Severe COVID-19: The Prognostic Value of Factor XIII Decline and Elevated D-Dimers Christopher Cibis, Elisabeth Hannah Adam, Florian Gatzke, Steffen Rauchfuss, Stefanie Roth, Wolfgang Miesbach
3 [GO] 2025―May―21 Activated Partial Thromboplastin Time and Anti-IIa Monitoring in Argatroban Anticoagulation in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation Filip Burša, Michal Frelich, Peter Sklienka, Simona Němcová, Zuzana Kučerová, Ondřej Jor, et al. (+5)
4 [GO] 2025―Feb―13 Immature Platelets and Platelet Reactivity in Patients with COVID-19 Yulia Balmakov, Tomer Mark, Itzik Barnett, Michal Cipok, Eli I. Lev, Amir Cohen, et al. (+2)
5 [GO] 2025―Feb―13 Cardiovascular Symposium on Perspectives in Long COVID Robert S. Dieter, Prakasha Kempaiah, Elizabeth G. Dieter, Andrew Alcazar, Alfonso Tafur, Grigoris Gerotziafas, et al. (+10)
6 [GO] 2025―Jan―07 Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 Patients Alejandro J Gonzalez-Ochoa, Gyozo Szolnoky, Ana G Hernandez-Ibarra, Jawed Fareed
7 [GO] 2024―Nov―12 Association Between Coagulation Fibrinolysis Markers and Severity in Patients with COVID-19 Takuya Iwamoto, Yuki Hatayama, Noriko Yamashita, Hitomi Ichikawa, Koji Kawamura
8 [GO] 2024―Nov―05 Frequency and Association of Polymorphisms in F2, F7, and PROS1 Coagulation Genes with Disease Severity in Coronavirus Disease 2019 Dalal Sulaiman Alshaya, Lama A. Alzamil, Alanoud S. Alghamdi, Lolwah S. Alshammari, Saltana A. Alhowaiti, Marie Fe F. Bohol, et al. (+6)
9 [GO] 2024―Jun―04 What Is the Impact of Baseline Inflammatory and Hemostatic Indicators with the Risk of Mortality in Severe Inpatients with COVID-19: A Retrospective Study Huiqi Zhu, Yeping Li, Hua Su, Chao Yan, Wanghao Xin, Kejing Ying
10 [GO] 2024―Mar―29 Sex Differences and Clinical Outcomes of Patients with Coronavirus Disease 2019 Infection and Cerebral Venous Sinus Thrombosis: A Systematic Review Saleh A. Algarni, Naif S. ALGhasab, Mohammed S. Alharbi, Anas Albarrak, Ahmad A. Alanezi, Hamdan M. Al Shehri
11 [GO] 2023―Dec―15 Impact of Concomitant Thrombotic Thrombocytopenic Purpura on COVID-19 Mortality and Morbidity: A Nationwide Inpatient Sample Analysis Ali Jaan, Zouina Sarfraz, Farhan Khalid, Junaid Anwar
12 [GO] 2023―Dec―11 The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Ramesh Vishwakarma, Mashael AlFaifi, et al. (+14)
13 [GO] 2023―Oct―30 Impact of New Onset Atrial Fibrillation in Hospitalized Patients with COVID-19. Results of the “ACO-VID” Registry Juan José Cerezo Manchado, Teodoro Iturbe Hernández, María del Carmen Martínez Pacheco, Ignacio Gil Ortega, Desirée Campoy, Tania Canals Pernas, et al. (+6)
14 [GO] 2023―Aug―07 Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis Awatif Hafiz, Hadeel Alkofide, Khalid Al Sulaiman, Hala Joharji, Sarah Aljohani, Khadijah A. Sarkhi, et al. (+5)
15 [GO] 2023―Jul―05 Mean Platelet Volume may not be an Indicator of the Risk of Venous Thrombosis in COVID-19 Patients Cengiz Beyan, Esin Beyan
16 [GO] 2023―Jun―16 Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Lina I. Alnajjar, Ali F. Altebainawi, Mashael AlFaifi, et al. (+19)
17 [GO] 2023―Jun―07 Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation Pável Olivera, César Velásquez-Escandón, Desirée Campoy, Katia Flores, Tania Canals, Erik Johansson, et al. (+4)
18 [GO] 2023―May―25 Lymphocytes, Mean Platelet Volume, and Albumin in Critically Ill COVID-19 Patients with Venous Thromboembolism Rundan Duan, Qihong Ni, Yinan Li, Mingli Zhu, Wen Li, Peng Wang, et al. (+5)
19 [GO] 2023―May―19 Thrombosis Occurrence in COVID-19 Compared With Other Infectious Causes of ARDS: A Contemporary Cohort Andréa Coy-Canguçu, Gisele A. Locachevic, João Carlos S. Mariolano, Kaio Henrique De O. Soares, José Diogo Oliveira, Camila De Oliveira Vaz, et al. (+5)
20 [GO] 2023―May―03 Efficacy and Safety of Direct Oral Anticoagulants Compared With Heparin for Preventing Thromboembolism in Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis Yong Tian, Tao Pan, Xudong Wen, Guangyu Ao, Yihan Ma, Xiaoxiao Liu, et al. (+2)
21 [GO] 2023―Feb―15 Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19 Raed Kensara, Ohoud Aljuhani, Ghazwa B Korayem, Hadeel Alkofide, Sumaya N Almohareb, Yousef S Alosaimi, et al. (+19)
22 [GO] 2023―Feb―01 The Efficacy and Safety of Prolonged Oral Anticoagulation for the Prevention of Thromboembolic Events in Patients Recovered From COVID-19 1 Year After Hospital Discharge: The SARCOV-19 Prospective Registry Ghizlane El Aidouni, Amine Bouchlarhem, Houssam Bkiyar, Nabila Ismaili, Noha El Ouafi, Brahim Housni
23 [GO] 2023―Jan―03 Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis Forough Mehrabi, Melina Farshbafnadi, Nima Rezaei
24 [GO] 2022―Dec―27 Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) Daniel Aston, Martin Besser, Ben Goddard, Nicholas Maggs, Hassan Ahmed, Florian Falter
25 [GO] 2022―Dec―23 Correction of Anticoagulant Therapy in Patients with Severe COVID-19 Virus Infection Using a Thrombodynamics Coagulation Assay Tatiana S. Vuimo, Sergey V. Tsarenko, Elena V. Filimonova, Elena A. Seregina, Sergey S. Karamzin
26 [GO] 2022―Dec―14 The Impact of Prior Antithrombotic use on Thromboembolic Events in Patients with Cardiovascular Disease and Severe COVID-19 Infection Amine Bouchlarhem, Soumia Boulouiz, Ghizlane el Aidouni, Houssam Bkiyar, Zakaria Bazid, Nabila Ismaili, et al. (+2)
27 [GO] 2022―Nov―17 Recent Findings on Platelet Activation, vWF Multimers and Other Thrombotic Biomarkers Associated with Critical COVID-19 Guadalupe Damián-Vázquez, Nallely García-Larragoiti, Alan Cano-Méndez, Patricia Guzmán-Cancino, Aidyl Tiznado-Leyva, Sandra López-Castaneda, Martha Eva Viveros-Sandoval
28 [GO] 2022―Nov―12 Assessment of Healthcare Resource Utilization by Anticoagulant Heparinoid Dosage Level in Patients Hospitalized with COVID-19 Keith Robinson, Laura L. Schott, Tom Matthews, Manu Tyagi, Vivek B. Ajmani, Nancy Sacco, Zhun Cao
29 [GO] 2022―Oct―26 In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin Moudhi Alroomi, Ahmad Alsaber, Bader Al-Bader, Farah Almutairi, Haya Malhas, Jiazhu Pan, et al. (+9)
30 [GO] 2022―Sep―29 Association of Lupus Anticoagulant status with Disease Course in SARS-CoV-2 (COVID-19) Infection Suhyeon Woo, Bohyun Kim, Nam Hun Heo, Min-sun Kim, Young Ahn Yoon, Young-Jin Choi
31 [GO] 2022―Aug―23 Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United States W. Frank Peacock, James M. Crawford, Yen-Wen (Cindy) Chen, Veronica Ashton, Alicia K. Campbell, Dejan Milentijevic, Alex C. Spyropoulos
32 [GO] 2022―Aug―09 D-dimer Thresholds to Exclude Pulmonary Embolism among COVID-19 Patients in the Emergency Department: Derivation with Independent Validation Joseph R. Bledsoe, Daniel Knox, Ithan D. Peltan, Scott C. Woller, James F. Lloyd, Gregory L. Snow, et al. (+3)
33 [GO] 2022―Aug―04 Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019 Adham Mohamed, Shelby M Shemanski, Mohamed O Saad, Jeannette Ploetz, Michelle M Haines, Andrew B Schlachter, Majdi S Hamarshi
34 [GO] 2022―Jul―29 Clot Stiffness Measured By Seer Sonorheometry As a Marker Of Poor Prognosis In Hospitalized COVID-19 Patients Francisco José López-Jaime, Ihosvany Fernández-Bello, Sandra Martín-Téllez, Alberto Doblas-Márquez, Yohannes Tesfay, Ignacio Márquez-Gómez, et al. (+3)
35 [GO] 2022―Jul―18 Development and Implementation of an Online Global Pharmacovigilance Certificate Program During the COVID-19 Pandemic Thao Doan, Fabio Lievano, Linda Scarazzini, Kate Liebelt, Mark Jaradeh, Bulent Kantarcioglu, et al. (+2)
36 [GO] 2022―Jun―29 Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19 Wei Xia, Yafeng Tan, Shengmei Hu, Chengbin Li, Tao Jiang
37 [GO] 2022―Jun―14 COVID-19 Infection in Patients with Comorbidities: Clinical and Immunological Insight Omnia El-Badawy, Nahla M. Elsherbiny, Doaa Abdeltawab, Doaa M. Magdy, Lamees M. Bakkar, Shimaa A. Hassan, et al. (+12)
38 [GO] 2022―Jun―06 Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study Shmeylan Al Harbi, Raed Kensara, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Abdullah Al Harthi, et al. (+18)
39 [GO] 2022―May―10 Correspondence on COVID-19 Vaccination and Acquired Haemophila A Pathum Sookaromdee, Viroj Wiwanitkit
40 [GO] 2022―Apr―05 Haemostatic Disarray Following COVID-19 Vaccine - a Case of Acquired Haemophila A Evelyn O'Shea, Orna Daly, Cleona Duggan, Maeve Crowley
41 [GO] 2022―Apr―01 Acute Myocardial Injury Assessed by High-Sensitive Cardiac Troponin Predicting Severe Outcomes and Death in Hospitalized Patients with COVID-19 Infection Falmata Laouan Brem, Miri Chaymae, Hammam Rasras, Manal Merbouh, Mohammed-Amine Bouazzaoui, Houssam Bkiyar, et al. (+5)
42 [GO] 2022―Mar―29 Rotational Thromboelastometry Profile among Critically ill COVID-19 Patients Indalecio Carboni Bisso, Iván Huespe, Eduardo Prado, Melina Garbarini, Marina Sol López, Luis Barrera, et al. (+3)
43 [GO] 2022―Mar―25 Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients? Győző Szolnoky, Alejandro José González-Ochoa
44 [GO] 2022―Mar―21 Report of Low Incidence of Thrombosis with Early Prophylaxis in Hospitalized Patients with COVID-19 from Two Saudi Tertiary Centers Tarek Owaidah, Khalid Maghrabi, Feras Alfraih, Alfadil Haroon, Khawar Siddiqui, Randa Alnounou, et al. (+5)
45 [GO] 2022―Mar―21 Factor VIII, Fibrinogen and Heparin Resistance in COVID-19 Patients with Thromboembolism: How Should We Manage the Anticoagulation Therapy? Felicio Savioli, Maurício Claro, Fernando Jose da Silva Ramos, Laerte Pastore
46 [GO] 2022―Mar―18 Improving Care of Older Patients with Hemophilia During COVID-19 Pandemic, Reducing the Risk of Venous Thrombosis with Home Exercises Ufuk Demirci, Elif G. Umit, Hande Ozdemir, Derya Demirbag Kabayel, Ahmet Muzaffer Demir
47 [GO] 2022―Mar―11 Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia Guillaume Roberge, Marc Carrier
48 [GO] 2022―Feb―15 An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations Bulent Kantarcioglu, Omer Iqbal, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio Lievano, et al. (+5)
49 [GO] 2022―Feb―02 Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination Mona Al-Ahmad, Mona Al Rasheed, Neveen Shalaby, Tito Rodriguez-Bouza, Lulwa Altourah
50 [GO] 2022―Jan―24 Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review Michael Joseph Cryer, Serdar Farhan, Christoph C. Kaufmann, Bernhard Jäger, Aakash Garg, Prakash Krishnan, et al. (+2)
51 [GO] 2021―Dec―22 Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis Rostami Mehrdad, Khoshnegah Zahra, Hassan Mansouritorghabeh
52 [GO] 2021―Dec―15 Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Susan Guy, Steve Kitchen, Michael Makris, Rhona M. Maclean, Giorgia Saccullo, Joost J Vanveen
53 [GO] 2021―Dec―15 Thrombotic and Hemorrhagic Incidences in Patients After Discharge from COVID-19 Infection: A Systematic Review and Meta-Analysis Tarinee Rungjirajittranon, Weerapat Owattanapanich, Nattawut Leelakanok, Natthaporn Sasijareonrat, Bundarika Suwanawiboon, Yingyong Chinthammitr, Theera Ruchutrakool
54 [GO] 2021―Dec―15 Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey Bulent Kantarcioglu, Krishan Patel, Joseph Lewis, Omer Iqbal, Fakiha Siddiqui, Nusrat Jabeen, et al. (+3)
55 [GO] 2021―Dec―15 Diagnostic Accuracy of D-Dimers for Predicting Pulmonary Embolism in COVID-19-Patients Falmata Laouan Brem, Boudouh Asmae, Yassine Amane, Mohammed-Amine Bouazzaoui, Miri Chaymae, Hammam Rasras, et al. (+7)
56 [GO] 2021―Dec―15 Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review Usama Waqar, Shaheer Ahmed, Syed M.H.Ali Gardezi, Muhammad Sarmad Tahir, Zain ul Abidin, Ali Hussain, et al. (+2)
57 [GO] 2021―Nov―17 D-dimer, COVID-19 and Diabetes: A Correspondence Sora Yasri, Viroj Wiwanitkit
58 [GO] 2021―Nov―17 Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study Heidi Worth, Kasey Helmlinger, Renju Raj, Eric Heidel, Ronald Lands
59 [GO] 2021―Nov―15 Extensive Arterial, Venous and Intracardiac Thrombosis in a Patient After Recovery From COVID-19 Priyal Agarwal, Issa Haddad
60 [GO] 2021―Nov―10 A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19 Mark Klein, Vinh Dao, Fatima Khan
61 [GO] 2021―Nov―10 Thrombosis After Adenovirus-Vectored COVID-19 Vaccination: A Concern on Underlying Illness Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
62 [GO] 2021―Oct―29 Significance of MPV, RDW and PDW with the Severity and Mortality of COVID-19 and Effects of Acetylsalicylic Acid Use Faruk Aydınyılmaz, Emrah Aksakal, Hilal Erken Pamukcu, Selim Aydemir, Remziye Doğan, İbrahim Saraç, et al. (+4)
63 [GO] 2021―Oct―29 Low Incidence of Symptomatic Thrombotic Events in Adult Patients Hospitalized with Coronavirus 19: A Retrospective Cohort Study Marcelo G. Vallone, Carolina Vazquez, Fernando A. Chuliber, Verónica Privitera, Augusto Ferraris, Ramiro F. Cantarella, et al. (+4)
64 [GO] 2021―Oct―26 COVID-19 Vaccine-Associated Thrombosis With Thrombocytopenia Syndrome (TTS): A Systematic Review and Post Hoc Analysis Muhammad Usman Hafeez, Maha Ikram, Zunaira Shafiq, Azza Sarfraz, Zouina Sarfraz, Vikash Jaiswal, et al. (+2)
65 [GO] 2021―Oct―25 Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum? Patrick Van Dreden, Jawed Fareed, Ismail Elalamy, Grigoris Gerotziafas
66 [GO] 2021―Oct―23 Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19 Zahra Elyaspour, Mohammad Javad Zibaeenezhad, Mahboobeh Razmkhah, Iman Razeghian-Jahromi
67 [GO] 2021―Oct―01 Anticoagulation for COVID-19 Patients: A Bird's-Eye View Firas Kreidieh, Sally Temraz
68 [GO] 2021―Sep―30 D-dimer Level and Diabetes in the COVID-19 Infection Chaymae Miri, Hajar Charii, Mohammed-Amine Bouazzaoui, Falmata Laouan Brem, Soumia boulouiz, Naima Abda, et al. (+4)
69 [GO] 2021―Sep―30 Dengue After COVID-19 Vaccination: Possible and Might be Missed Amnuay Kebayoon, Viroj Wiwanitkit
70 [GO] 2021―Sep―20 Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination MA Haimei
71 [GO] 2021―Sep―09 Safety Interval From Increased Viscosity After COVID-19 Vaccination Among Persons With Cerebrovascular Problems Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
72 [GO] 2021―Jun―30 Acetylsalicylic Acid and COVID-19 Prevention: A Comment Pathum Sookaromdee, Viroj Wiwanitkit
73 [GO] 2021―Jun―29 Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity Mehmet Gökhan Gönenli, Zeynep Komesli, Said İncir, Özlem Yalçın, Olga Meltem Akay
74 [GO] 2021―Jun―25 Clinical Features of COVID-19 Patients With Venous Thromboembolism Kai Liang, Ying Fu, Yi Kang, Huanzhang Shao, Jianxu Yang, Mingzhe Cui, Shuiting Zhai
75 [GO] 2021―Jun―18 Evaluation of Bleeding Rate and Time in Therapeutic Range in Patients Using Warfarin Before and During the COVID-19 Pandemic-Warfarin Treatment in COVID-19 Zeynep Yapan Emren, Oktay Şenöz, Ahmet Erseçgin, Sadık Volkan Emren
76 [GO] 2021―Jun―18 Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19 Beuy Joob, Viroj Wiwanitkit
77 [GO] 2021―Jun―02 An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination Bulent Kantarcioglu, Omer Iqbal, Jeanine M. Walenga, Bruce Lewis, Joseph Lewis, Charles A. Carter, et al. (+7)
78 [GO] 2021―May―21 Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy Radu Crisan-Dabija, Alexandru Burlacu
79 [GO] 2021―May―20 The Meaning of D-Dimer value in Covid-19 Giulia Conte, Marco Cei, Isabella Evangelista, Alessandra Colombo, Josè Vitale, Antonino Mazzone, Nicola Mumoli
80 [GO] 2021―Apr―30 Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients? Federico Cacciapuoti, Fulvio Cacciapuoti
81 [GO] 2021―Apr―30 Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression Haoting Zhan, Haizhen Chen, Chenxi Liu, Linlin Cheng, Songxin Yan, Haolong Li, Yongzhe Li
82 [GO] 2021―Apr―28 Blood Viscosity at the First Clinical Presentation in Fatal and Non-Fatal COVID-19: An Observation Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
83 [GO] 2021―Apr―20 Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Chatphatai Moonla, Darintr Sosothikul, Thita Chiasakul, Ponlapat Rojnuckarin, Noppacharn Uaprasert
84 [GO] 2021―Apr―09 Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection Sandra Lopez-Castaneda, Nallely García-Larragoiti, Alan Cano-Mendez, Kenia Blancas-Ayala, Guadalupe Damian-Vázquez, Ana Itzel Perez-Medina, et al. (+3)
85 [GO] 2021―Apr―08 ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study Joel G. Ray, Marian J. Vermeulen, Michael J. Schull, Alison L. Park
86 [GO] 2021―Apr―05 Clinical Outcomes of Pulmonary Embolism in Mexican Patients With COVID-19 Luis O. Bobadilla-Rosado, Santiago Mier y Teran-Ellis, Gabriel Lopez-Pena, Javier E. Anaya-Ayala, Carlos A. Hinojosa
87 [GO] 2021―Mar―31 Role of Tissue Factor in the Pathogenesis of COVID-19 and the Possible Ways to Inhibit It Carlos A. Cañas, Felipe Cañas, Mario Bautista-Vargas, Fabio Bonilla-Abadía
88 [GO] 2021―Mar―30 Considerations for Patients With Peripheral Artery Disease During the COVID-19 Pandemic Serdar Farhan, Haroon Kamran, Birgit Vogel, Karan Garg, Ajit Rao, Navneet Narula, et al. (+9)
89 [GO] 2021―Mar―24 Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose Zhenzhou Wang, Zhe Du, Xiujuan Zhao, Fuzheng Guo, Tianbing Wang, Fengxue Zhu
90 [GO] 2021―Feb―11 Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis Azza Sarfraz, Zouina Sarfraz, Aminah Abdul Razzack, Gaurav Patel, Muzna Sarfraz
91 [GO] 2021―Feb―10 Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection Harry N. Magnani
92 [GO] 2021―Jan―15 Systemic Coagulopathy in Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Noppacharn Uaprasert, Chatphatai Moonla, Darintr Sosothikul, Ponlapat Rojnuckarin, Thita Chiasakul
93 [GO] 2020―Dec―29 Deep Venous Thrombosis in COVID-19 Patients: A Cohort Analysis Chuanqi Cai, Yi Guo, Yun You, Ke Hu, Fei Cai, Mingxing Xie, et al. (+6)
94 [GO] 2020―Oct―20 COVID-19 and Hypercoagulability: A Review Asim Kichloo, Kirk Dettloff, Michael Aljadah, Michael Albosta, Shakeel Jamal, Jagmeet Singh, et al. (+4)
95 [GO] 2020―Oct―20 The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review Indra Wijaya, Rizky Andhika, Ian Huang
96 [GO] 2020―Oct―20 Prevalence and Risk Factors of Thromboembolism among Patients With Coronavirus Disease-19: A Systematic Review and Meta-Analysis Belayneh Kefale, Gobezie T. Tegegne, Amsalu Degu, Melaku Tadege, Desalegn Tesfa
97 [GO] 2020―Oct―15 Is Thrombophilic Genetic Profile Responsible for an Acute Ischemic Stroke in a COVID-19 Male Patient? Alexandru Burlacu, Bogdan Artene, Radu Crisan-Dabija, Iolanda Valentina Popa, Adrian Covic
98 [GO] 2020―Oct―08 A Retrospective Analysis of the Coagulation Dysfunction in COVID-19 Patients Xu Chen, Qinghua Wang, Min Xu, Chengbin Li
99 [GO] 2020―Sep―16 Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review Nicholas Kipshidze, Patrick Iversen, Thomas R. Porter, Nodar Kipshidze, Fakiha Siddiqui, George Dangas, Jawed Fareed
100 [GO] 2020―Sep―16 Anticoagulation in COVID-19: DDI Perspective Sajad Khiali, Taher Entezari-Maleki
101 [GO] 2020―Sep―04 Methodological Issues and Controversies in COVID-19 Coagulopathy: A Tale of Two Storms Samuel A Berkman, Victor F Tapson
102 [GO] 2020―Sep―02 Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 Pandemic Faisal Alsayegh, Shaker A. Mousa
103 [GO] 2020―Aug―28 Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients Yuan Yu, Jie Tu, Bingxin Lei, Huaqing Shu, Xiaojing Zou, Ruiting Li, et al. (+3)
104 [GO] 2020―Aug―26 COVID-19, Antiphospholipid Syndrome and Thrombosis Sora Yasri, Viroj Wiwanitkit
105 [GO] 2020―Aug―26 Unpuzzling COVID-19 Prothrombotic State: Are Preexisting Thrombophilic Risk Profiles Responsible for Heterogenous Thrombotic Events? Alexandru Burlacu, Simonetta Genovesi, Iolanda Valentina Popa, Radu Crisan-Dabija
106 [GO] 2020―Aug―21 Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic Kaveh Rezaei Bookani, Iva Minga, Manisha Chander, Ksenia Hankewych, Matthew Plassmeier, Alfonso Tafur
107 [GO] 2020―Aug―14 COVID-19 Associated Coagulopathy and Thrombotic Complications Zoubida Tazi Mezalek, Hajar Khibri, Wafaa Ammouri, Majdouline Bouaouad, Soukaina Haidour, Hicham Harmouche, et al. (+2)
108 [GO] 2020―Jul―31 COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response Apoorva Jayarangaiah, Pramod Theetha Kariyanna, Xiaoyi Chen, Amog Jayarangaiah, Abhishek Kumar
109 [GO] 2020―Jul―31 Coronavirus Disease and Acute Vascular Events Gundu H. R. Rao
110 [GO] 2020―Jul―29 Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan Jianpu Chen, Xiang Wang, Shutong Zhang, Bin Lin, Xiaoqing Wu, Yanfang Wang, et al. (+4)
111 [GO] 2020―Jul―29 Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications MA Haimei
112 [GO] 2020―Jul―24 Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19 Galit H. Frydman, Edward W. Boyer, Rosalynn M. Nazarian, Elizabeth M. Van Cott, Gregory Piazza
113 [GO] 2020―Jul―22 Pulmonary Embolism, Pulmonary Microvascular Thrombosis, or Both in COVID-19? José A. Páramo
114 [GO] 2020―Jul―20 Viral Coagulopathy in Patients With COVID-19: Treatment and Care Nickolas Kipshidze, George Dangas, Christopher J. White, Nodar Kipshidze, Fakiha Siddiqui, Christopher R. Lattimer, et al. (+2)
115 [GO] 2020―Jul―17 COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation Wolfgang Miesbach, Michael Makris
116 [GO] 2020―Jul―13 Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium? Nil Guler, Fakiha Siddiqui, Jawed Fareed
117 [GO] 2020―Jul―10 Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020 Eduardo Ramacciotti, Ariane Scarlatelli Macedo, Rodrigo Bruno Biagioni, Roberto Augusto Caffaro, Renato Delascio Lopes, João Carlos Guerra, et al. (+8)
118 [GO] 2020―Jul―10 Reducing the Risk of Venous Thrombosis During Self-Isolation and COVID-19 Pandemic for Patients With Cancer: Focus on Home Exercises Prescription Ufuk Demirci, Hande Ozdemir, Derya Demirbag-Kabayel, Elif G. Umit, Ahmet Muzaffer Demir
119 [GO] 2020―Jul―03 COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets Erkan Cure, Medine Cumhur Cure
120 [GO] 2020―Apr―06 Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients Beuy Joob, Viroj Wiwanitkit
 [1] 

120 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.006 sec